- Home
- HHH vs CAI Comparison
HHH vs CAI Comparison
Compare HHH & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HHH | CAI |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 6.0B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | HHH | CAI |
|---|---|---|
| Price | $83.62 | $21.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $90.00 | $34.71 |
| AVG Volume (30 Days) | 336.9K | ★ 2.5M |
| Earning Date | 02-19-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 234.52 | N/A |
| EPS | ★ 5.10 | N/A |
| Revenue | ★ $1,834,033,000.00 | $649,062,000.00 |
| Revenue This Year | N/A | $81.66 |
| Revenue Next Year | $19.38 | $33.47 |
| P/E Ratio | $16.64 | ★ N/A |
| Revenue Growth | 69.81 | ★ 112.02 |
| 52 Week Low | $61.41 | $21.18 |
| 52 Week High | $91.07 | $42.50 |
Technical Indicators
Market Signals| Indicator | HHH | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 31.92 |
| Support Level | $79.64 | $21.18 |
| Resistance Level | $85.56 | $23.00 |
| Average True Range (ATR) | 2.09 | 1.30 |
| MACD | 0.35 | -0.26 |
| Stochastic Oscillator | 65.31 | 13.07 |
Price Performance
Historical ComparisonAbout HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.